| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/08/2009 | WO2008109433A4 Anti-angiogenic peptides |
| 01/08/2009 | US20090012275 Means and methods for mediating protein interference |
| 01/08/2009 | US20090012264 Microwave-Assisted Peptide Synthesis |
| 01/08/2009 | US20090012262 Forisomes, Method for Their Isolation, and Their Use as a Molecular Working Machine |
| 01/08/2009 | US20090012261 HLA Epitope Identification |
| 01/08/2009 | US20090012004 HLA binding peptides and their uses |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090012002 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 01/08/2009 | US20090011997 Bifunctional hormone and uses thereof |
| 01/08/2009 | US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 01/08/2009 | US20090011988 Method for treating cartilage disorders |
| 01/08/2009 | US20090011981 Novel Inhibitors of Angiogenesis |
| 01/08/2009 | US20090011977 Novel Lipopeptides as Antibacterial Agents |
| 01/08/2009 | US20090011497 Peptides and related compounds having thrombopoietic activity |
| 01/08/2009 | US20090011427 Assays for preimplantation factor and preimplantation factor peptides |
| 01/08/2009 | US20090011426 Methods of Diagnosis and Treatment of M.Tuberculosis Infection and Reagents Therefor |
| 01/08/2009 | US20090010967 Clostridial toxin derivatives and methods for treating pain |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| 01/08/2009 | US20090010924 Apoptotic Anti-IgE Antibodies |
| 01/08/2009 | US20090010922 Compositions and methods for binding sphingosine-1-phosphate |
| 01/08/2009 | CA2692603A1 Peptides facilitating retrograde transport and their uses |
| 01/07/2009 | EP2012125A1 Molecular modification assays |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2010227A2 Radiofluorinated compounds and their preparation |
| 01/07/2009 | EP2010203A2 Macrocyclic peptides and methods for making and using them |
| 01/07/2009 | EP2010202A2 Novel antibacterial compounds |
| 01/07/2009 | EP2010138A1 Peptide-based body surface coloring reagents |
| 01/07/2009 | EP1629002B1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 01/07/2009 | EP1581790B1 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 01/07/2009 | EP1103564B1 Cancer antigens based on tumor suppressor gene wt1 product |
| 01/07/2009 | EP0787008B1 Thymosin alpha1 in combination with a natural cytokine mixture for the treatment of a cellular immune deficiency |
| 01/07/2009 | CN101337985A Self-assembly short peptides constructed by D type amino acid, use for nano-biomedicine |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473760 Cyclic peptide compositions for treatment of sexual dysfunction |
| 01/06/2009 | US7473682 Angiogenic peptides and uses thereof |
| 01/01/2009 | US20090005535 Solution-Phase Synthesis of Leuprolide and Its Intermediates |
| 01/01/2009 | US20090005534 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005316 Alpha-conotoxin mii analogs |
| 01/01/2009 | US20090005294 Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors |
| 01/01/2009 | US20090004696 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 01/01/2009 | US20090004214 Cd4+ Survivin Epitopes and Uses Thereof |
| 01/01/2009 | US20090004210 Method for Preventing and Treating Alzheimer's Disease |
| 12/31/2008 | WO2009002274A1 Cationic peptide for delivering an agent into a cell |
| 12/31/2008 | WO2009001928A1 Peptide having hypotensive activity |
| 12/31/2008 | WO2009000137A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agnet, a method for modifying the agent and its use for manufacturing a medicament for treating tumor |
| 12/31/2008 | WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides |
| 12/31/2008 | WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/31/2008 | WO2009000017A1 Peptides as antimicrobial agents towards campylobacter spp |
| 12/31/2008 | WO2008108941A3 Integrated photoactive peptides and uses thereof |
| 12/31/2008 | WO2007140284A3 N-terminally modified glp-1 receptor modulators |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009018A2 T cell antigen receptor peptides |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2007794A1 Lysobactin amides |
| 12/31/2008 | EP2007793A1 Bacterial vaccine |
| 12/31/2008 | EP2007792A2 Cholesterol lowering protein hydrolysates |
| 12/31/2008 | EP2007791A2 Modified molecules which promote hematopoiesis |
| 12/31/2008 | EP2007790A1 Compounds and methods for the treatment of pain |
| 12/31/2008 | EP1758924B1 Peptides antagonists for inhibiting heat shock protein (hsp 16.3) of mycobacterium tuberculosis |
| 12/31/2008 | EP1718760B1 Protein phosphorylation in c-src signaling pathways |
| 12/31/2008 | EP1718323A4 Binding peptidomimetics and uses of the same |
| 12/31/2008 | EP1664095B1 Antimicrobial polypeptides |
| 12/31/2008 | EP1367961B1 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 12/31/2008 | EP1309610B1 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 12/31/2008 | CN101336249A 新型肽化合物 Novel peptide compounds |
| 12/31/2008 | CN101333249A Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 12/31/2008 | CN101333248A B cell antigen epitope polypeptide of encephalitis B virus E protein and uses thereof |
| 12/31/2008 | CN101333247A Antimicrobial peptide separated from skin of Northeast China brown frog and applications in antibacterials |
| 12/31/2008 | CN101333246A Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof |
| 12/31/2008 | CN100447153C Preparing process and application of undecapeptide |
| 12/31/2008 | CA2728140A1 Peptide tyrosinase inhibitors and uses thereof |
| 12/31/2008 | CA2728122A1 Oligopeptide tyrosinase inhibitors and uses thereof |
| 12/31/2008 | CA2690943A1 Conjugates containing hydrophilic spacer linkers |
| 12/31/2008 | CA2690371A1 Peptide having hypotensive activity |
| 12/31/2008 | CA2687159A1 Peptides as antimicrobial agents towards campylobacter spp |
| 12/30/2008 | US7470664 HCV NS3 protease inhibitors |
| 12/30/2008 | US7470658 Methods for inhibiting tumor metastasis, and peptides useful therefor |
| 12/25/2008 | US20080319183 Branched Polymeric Sugars and Nucleotides Thereof |
| 12/25/2008 | US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide |
| 12/25/2008 | US20080319164 Synthesis and application of a family of new materials resulting from the chemical cross-linking between gelatine and organic salts |
| 12/25/2008 | US20080319163 Method for Isolating and Purifying Immuno-Modulating Polypeptide from Cow Placenta |
| 12/25/2008 | US20080319162 Process and Intermediates for the Synthesis of Caspofungin |
| 12/25/2008 | US20080318868 Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation |
| 12/25/2008 | US20080318849 Kahalalide F and Related Compounds |
| 12/25/2008 | US20080318848 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; anticarcinogenic agent; refractory cancer that does not respond favorably to other treatments; peptides isolated mollusc, Elysia Elysia rufescens and its diet, a green algae |
| 12/25/2008 | US20080318838 Peptides |
| 12/25/2008 | US20080318337 Method for Determining a Tissue Degradation Process by Detection of Comp Neoepitopes |
| 12/25/2008 | US20080318223 Large deletions in human brca1 gene and use thereof |
| 12/25/2008 | US20080317837 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 12/25/2008 | US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317668 Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications |
| 12/24/2008 | WO2008157729A2 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 12/24/2008 | WO2008157483A2 Polypeptides and methods of use |